PMID: 6171865Jan 1, 1981Paper

Treatment of human complement components C4 and C3 with amines or chaotropic ions. Evidence of a functional and structural change that provides uncleaved C4 and C3 with properties of their soluble activated froms, C4b and C3b

Scandinavian Journal of Immunology
I von ZabernW Vogt

Abstract

Treatment of human components C4 and C3 with amines like hydrazine, ammonium hydroxide, and neutral ammonium salts or with chaotropic salts like KSCN and NaBr leads to complete loss of haemolytic activity. The pretreated components are, however, still active in formation of soluble C3 convertases. This activity pattern is reminiscent of the activities of C4 and C3 that have been activated by cleavage in the fluid phase. Indeed, the antigenic properties of pretreated C4 and C3 are similar to soluble C4b and C3b. The polypeptide chain structure of pretreated C4 and C3, is, however, identical to that of the untreated components when investigated by SDS gel electrophoresis. Pretreatment even reduces greatly the susceptibility of C4 to cleavage by C1s and of C3 to cleavage by classical and alternative pathway C3 convertases. Pretreated components have lost the ability to combine with EAC1 and EAC142, respectively; this fact explains their failure to exhibit haemolytic activity. In serum, pretreated C4 and C3 are cleaved in a manner similar to C4b and C3b. Amines and chaotropic ions cause the same functional and structural alterations, which are best explained by assumption of a conformational change. A similar transformation can als...Continue Reading

References

Mar 1, 1979·The Biochemical Journal·N A BoothJ E Fothergill
Oct 1, 1978·The Journal of Experimental Medicine·T FujitaV Nussenzweig
Dec 1, 1975·Immunochemistry·S Shiraishi, R M Stroud
Sep 1, 1977·The Biochemical Journal·I GigliR R Porter
Dec 1, 1977·The Journal of Experimental Medicine·M P Dierich, B Landen
Sep 1, 1976·The Biochemical Journal·I GigliR B Sim
Dec 1, 1973·Analytical Biochemistry·W Schaffner, C Weissmann
Sep 1, 1965·Immunochemistry·G ManciniJ F Heremans
Feb 1, 1980·Molecular Immunology·R A Harrison, P J Lachmann
Jan 1, 1980·Molecular Immunology·R A Harrison, P J Lachmann
Sep 1, 1963·The Journal of Experimental Medicine·H J MUELLER-EBERHARD, C E BIRO
Jan 1, 1926·The Biochemical Journal·J GordonA Wormall

❮ Previous
Next ❯

Citations

Jan 1, 1984·Springer Seminars in Immunopathology·M K Pangburn, H J Müller-Eberhard
Jan 1, 1983·Springer Seminars in Immunopathology·B F Tack
Aug 1, 1983·Agents and Actions·W Vogt
Nov 23, 1987·Journal of Immunological Methods·Y SugitaM Tomita
Apr 1, 1988·Molecular Immunology·A Al SalihiM Fontaine
Nov 1, 1990·Molecular Immunology·T C FarriesJ P Atkinson
Jan 1, 1983·International Journal of Immunopharmacology·I von ZabernW Sachsenheimer
Feb 1, 1985·Molecular Immunology·W VogtR Nolte
Feb 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·M L ThomasB F Tack
Jan 28, 2005·Kidney International·Gopala K RanganWilliam G Couser
May 1, 1987·The Journal of Clinical Investigation·J P TolinsT H Hostetter
May 1, 1989·The Journal of Clinical Investigation·J A HalperinA Nicholson-Weller
Aug 1, 1989·The Journal of Clinical Investigation·M K Hostetter, G M Johnson
Mar 1, 1995·Kidney International·A VäkeväP Laurila
Jan 1, 1983·Annals of the New York Academy of Sciences·S K Law
Jan 1, 1983·Annals of the New York Academy of Sciences·R D Feinman
May 15, 1986·European Journal of Biochemistry·S J Perkins, R B Sim
Oct 1, 1986·Pathology·D L Gordon, M K Hostetter
Dec 13, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Yusheng Zhu, Ronald J Elin
Nov 1, 1981·Bioscience Reports·R D SchreiberH J Müller-Eberhard
Sep 14, 1981·FEBS Letters·E SimR B Sim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.